BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26314494)

  • 1. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.
    Xu S; Wang T; Song W; Jiang T; Zhang F; Yin Y; Jiang SW; Wu K; Yu Z; Wang C; Chen K
    Sci Rep; 2015 Aug; 5():13528. PubMed ID: 26314494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [miR-141-3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells].
    Wang C; Ouyang Y; Lu M; Wei J; Zhang H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):736-9. PubMed ID: 26062412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
    Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
    Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
    Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
    Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
    Larne O; Hagman Z; Lilja H; Bjartell A; Edsjö A; Ceder Y
    Carcinogenesis; 2015 Aug; 36(8):858-66. PubMed ID: 25969144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
    Pasqualini L; Bu H; Puhr M; Narisu N; Rainer J; Schlick B; Schäfer G; Angelova M; Trajanoski Z; Börno ST; Schweiger MR; Fuchsberger C; Klocker H
    Mol Endocrinol; 2015 Jul; 29(7):1037-54. PubMed ID: 26052614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
    Ebron JS; Shukla GC
    Prostate; 2016 Jun; 76(9):834-44. PubMed ID: 26988939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
    Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM
    Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
    Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
    Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.
    Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ
    Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.
    Lu J; Li X; Wang F; Guo Y; Huang Y; Zhu H; Wang Y; Lu Y; Wang Z
    Exp Cell Res; 2017 Oct; 359(2):319-326. PubMed ID: 28782557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells.
    Shiota M; Yokomizo A; Kashiwagi E; Takeuchi A; Fujimoto N; Uchiumi T; Naito S
    Free Radic Biol Med; 2011 Jul; 51(1):78-87. PubMed ID: 21539911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.